Interestingly, our findings align with previous reports indicating that the re-expression of silenced CD36 inhibits the proliferation, migration, and invasion of lung cancer cells, arresting the cell cycle at the G0/G1 phase [46]. Here, CD36 is linked to lung carcinoma.